Document Classification

Section Type: METHODS

Text: They were randomised to receive one of the following treatments : (i) a 7-day triple therapy comprising of rabeprazole (20 mg, b. i. d.) plus clarithromycin (500 mg, b. i. d.) and amoxycillin (1 g, b. i. d.) ; (ii) a 10-day triple therapy comprising the same scheme ; (iii) a 10-day sequential regimen comprising of rabeprazole (20 mg, b. i. d.) plus amoxycillin (1 g, b. i. d.) for 5 days followed by rabeprazole (20 mg, b. i. d.) plus clarithromycin (500 mg, b. i. d.) and tinidazole (500 mg, b. i. d.) for the next 5 days.